Koninklijke Philips (NYSE:PHG) Lowered to “Hold” Rating by StockNews.com

StockNews.com lowered shares of Koninklijke Philips (NYSE:PHG) from a buy rating to a hold rating in a research report released on Friday.

A number of other research firms have also recently commented on PHG. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Koninklijke Philips presently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Trading Up 0.0 %

PHG opened at $26.04 on Friday. Koninklijke Philips has a twelve month low of $19.75 and a twelve month high of $32.91. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. The company has a fifty day moving average of $26.37 and a 200-day moving average of $28.06. The stock has a market cap of $24.47 billion, a PE ratio of -30.99, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The company had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, sell-side analysts predict that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be given a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is currently -89.29%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. FMR LLC lifted its position in shares of Koninklijke Philips by 0.6% during the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Koninklijke Philips by 2.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,290,051 shares of the technology company’s stock valued at $108,624,000 after purchasing an additional 85,994 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its position in Koninklijke Philips by 87.7% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock worth $56,266,000 after acquiring an additional 1,038,321 shares during the period. Northern Trust Corp raised its position in Koninklijke Philips by 36.6% in the fourth quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company’s stock worth $40,734,000 after acquiring an additional 430,757 shares during the period. Finally, Causeway Capital Management LLC raised its position in Koninklijke Philips by 24.0% in the fourth quarter. Causeway Capital Management LLC now owns 1,566,850 shares of the technology company’s stock worth $39,673,000 after acquiring an additional 303,428 shares during the period. 13.67% of the stock is owned by institutional investors.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.